Skip to main content
. 2022 Mar 2;13:845418. doi: 10.3389/fimmu.2022.845418

Figure 4.

Figure 4

The molecular mechanisms of LINC00520 in different tumors. BC, breast cancer; PTC, papillary thyroid carcinoma; CRC, colorectal cancer; MM, melanoma; LUAD, lung adenocarcinoma; HNSCC, head and neck squamous cell carcinoma; NPC, nasopharyngeal carcinoma; NSCLC, non-small cell lung cancer.